🔎 Trials Near Me

Home › Neurologic Diseases › Virginia

Neurologic Diseases clinical trials in Virginia

5 studies for Neurologic Diseases are looking for participants at sites in Virginia.

Cities in Virginia

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Re:Cognition Health, Fairfax
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595

Product Surveillance Registry

  • Charlottesville
  • Fairfax
  • Falls Church
  • and 1 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #066, Arlington
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Fairfax
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

  • University of Virginia, Charlottesville
RecruitingPhase 2
Ages 65 and older · All sexes · Updated May 8, 2024 · NCT05565833

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.